Scientists from the Northwestern University have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer. Using breast cancer patient data taken from The Cancer Genome Atlas the team used powerful computational and bioinformatics … Continue reading Biomarker in an aggressive breast cancer is identified.